Annual CAPEX
$5.41 M
-$725.00 K-11.81%
31 December 2023
Summary:
Barinthus Biotherapeutics annual capital expenditures is currently $5.41 million, with the most recent change of -$725.00 thousand (-11.81%) on 31 December 2023. During the last 3 years, it has risen by +$5.12 million (+1747.44%). BRNS annual CAPEX is now -11.81% below its all-time high of $6.14 million, reached on 31 December 2022.BRNS CAPEX Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Quarterly CAPEX
$114.00 K
-$78.00 K-40.63%
30 September 2024
Summary:
Barinthus Biotherapeutics quarterly capital expenditures is currently $114.00 thousand, with the most recent change of -$78.00 thousand (-40.63%) on 30 September 2024. Over the past year, it has increased by +$78.00 thousand (+216.67%). BRNS quarterly CAPEX is now -96.23% below its all-time high of $3.02 million, reached on 30 June 2023.BRNS Quarterly CAPEX Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
TTM CAPEX
$461.00 K
+$78.00 K+20.37%
30 September 2024
Summary:
Barinthus Biotherapeutics TTM capital expenditures is currently $461.00 thousand, with the most recent change of +$78.00 thousand (+20.37%) on 30 September 2024. Over the past year, it has dropped by -$5.69 million (-92.51%). BRNS TTM CAPEX is now -94.59% below its all-time high of $8.52 million, reached on 30 June 2023.BRNS TTM CAPEX Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
BRNS CAPEX Performance
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1 y1 year | -11.8% | +216.7% | -92.5% |
| 3 y3 years | +1747.4% | -73.1% | -59.8% |
| 5 y5 years | - | - | - |
BRNS CAPEX High & Low
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
|---|---|---|---|---|---|---|---|
| 3 y | 3 years | -11.8% | +1747.4% | -96.2% | +174.5% | -94.6% | +20.4% |
| 5 y | 5 years | -11.8% | +1747.4% | -96.2% | +174.5% | -94.6% | +1995.5% |
| alltime | all time | -11.8% | +1747.4% | -96.2% | +174.5% | -94.6% | +1995.5% |
Barinthus Biotherapeutics CAPEX History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Sept 2024 | - | $114.00 K(-40.6%) | $461.00 K(+20.4%) |
| June 2024 | - | $192.00 K(-37.7%) | $383.00 K(-88.1%) |
| Mar 2024 | - | $308.00 K(-301.3%) | $3.21 M(-40.6%) |
| Dec 2023 | $5.41 M(-11.8%) | -$153.00 K(-525.0%) | $5.41 M(-12.0%) |
| Sept 2023 | - | $36.00 K(-98.8%) | $6.15 M(-27.8%) |
| June 2023 | - | $3.02 M(+20.6%) | $8.52 M(+12.8%) |
| Mar 2023 | - | $2.51 M(+327.8%) | $7.55 M(+23.1%) |
| Dec 2022 | $6.14 M | $586.00 K(-75.6%) | $6.14 M(+2.7%) |
| Sept 2022 | - | $2.41 M(+17.1%) | $5.98 M(+61.6%) |
| June 2022 | - | $2.05 M(+88.1%) | $3.70 M(+100.3%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Mar 2022 | - | $1.09 M(+157.5%) | $1.85 M(+61.1%) |
| Dec 2021 | $1.15 M(+291.1%) | - | - |
| Dec 2021 | - | $424.00 K(+231.3%) | $1.15 M(+25.0%) |
| Sept 2021 | - | $128.00 K(-36.6%) | $917.00 K(+12.0%) |
| June 2021 | - | $202.00 K(-48.5%) | $819.00 K(+23.5%) |
| Mar 2021 | - | $392.00 K(+101.0%) | $663.00 K(+126.3%) |
| Dec 2020 | $293.00 K | $195.00 K(+550.0%) | $293.00 K(+199.0%) |
| Sept 2020 | - | $30.00 K(-34.8%) | $98.00 K(+44.1%) |
| June 2020 | - | $46.00 K(+109.1%) | $68.00 K(+209.1%) |
| Mar 2020 | - | $22.00 K | $22.00 K |
FAQ
- What is Barinthus Biotherapeutics annual capital expenditures?
- What is the all time high annual CAPEX for Barinthus Biotherapeutics?
- What is Barinthus Biotherapeutics annual CAPEX year-on-year change?
- What is Barinthus Biotherapeutics quarterly capital expenditures?
- What is the all time high quarterly CAPEX for Barinthus Biotherapeutics?
- What is Barinthus Biotherapeutics quarterly CAPEX year-on-year change?
- What is Barinthus Biotherapeutics TTM capital expenditures?
- What is the all time high TTM CAPEX for Barinthus Biotherapeutics?
- What is Barinthus Biotherapeutics TTM CAPEX year-on-year change?
What is Barinthus Biotherapeutics annual capital expenditures?
The current annual CAPEX of BRNS is $5.41 M
What is the all time high annual CAPEX for Barinthus Biotherapeutics?
Barinthus Biotherapeutics all-time high annual capital expenditures is $6.14 M
What is Barinthus Biotherapeutics annual CAPEX year-on-year change?
Over the past year, BRNS annual capital expenditures has changed by -$725.00 K (-11.81%)
What is Barinthus Biotherapeutics quarterly capital expenditures?
The current quarterly CAPEX of BRNS is $114.00 K
What is the all time high quarterly CAPEX for Barinthus Biotherapeutics?
Barinthus Biotherapeutics all-time high quarterly capital expenditures is $3.02 M
What is Barinthus Biotherapeutics quarterly CAPEX year-on-year change?
Over the past year, BRNS quarterly capital expenditures has changed by +$78.00 K (+216.67%)
What is Barinthus Biotherapeutics TTM capital expenditures?
The current TTM CAPEX of BRNS is $461.00 K
What is the all time high TTM CAPEX for Barinthus Biotherapeutics?
Barinthus Biotherapeutics all-time high TTM capital expenditures is $8.52 M
What is Barinthus Biotherapeutics TTM CAPEX year-on-year change?
Over the past year, BRNS TTM capital expenditures has changed by -$5.69 M (-92.51%)